by Simon Fraser University CC0/Pixabay Scientists at Simon Fraser University (SFU) and the Lankenau Institute for Medical Research (LIMR) near Philadelphia have found that a drug discovered at SFU and patented several years ago may have potential lifesaving results in the treatment of conditions leading to sudden cardiac death. The drug, known as AR-787, was originally discovered...
UNIVERSITY OF ILLINOIS AT CHICAGO Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest. Because of this, the U.S. Food and Drug Administration has revoked emergency use authorization...
By Rich Haridy August 27, 2020 New preliminary research is suggesting a simple saliva test can detect the presence of a protein biomarker known to signal the occurrence of a heart attack in just 10 minutes. If this prototype test is validated in future studies it could dramatically accelerate the speed at which patients with...
A compound common in pickled capers, quercetin, activates proteins required for normal human brain and heart activity, researchers report. In a new study in Communications Biology, the researchers report that quercetin can directly regulate proteins required for bodily processes such as the heartbeat, thought, muscular contraction, and normal functioning of the thyroid, pancreas, and gastrointestinal...
This article by Dr. Vivekanandan Palaninathan et al. is published in Current Pharmaceutical Design, 2020 BENTHAM SCIENCE PUBLISHERS Direct reprogramming or Transdifferentiation is a way of inducing changes in the cell type from one lineage into another lineage, bypassing pluripotency. This approach is an innovative choice to replace the lost cardiomyocytes after an end-stage myocardial...
The term Regenerative Medicine covers so much biomedical science these days including everything from just about any kind of cell therapy (not just stem cells) to CRISPR gene editing, and with the the COVID-19 pandemic, it seems this umbrella use of the term now includes potential treatment of viral illnesses. It can be hard to...
A novel electrocardiogram (ECG) method which uses signals from the ear and hand to check heart rhythm is revealed today at EHRA 2011 a European Society of Cardiology (ESC) congress. The ECG does not require two hands and could be used by drivers, athletes, and the military. Study author Dr. Raffaele De Lucia, of the University Hospital of Pisa, Italy, said: “Mobile ECG devices present a major opportunity to...
(HealthDay)—The six-minute walk distance (6MWD) test is useful in identifying patients with a higher likelihood of developing postoperative cognitive dysfunction (POCD) following cardiac surgery, according to a study published online May 9 in the Annals of Thoracic Surgery. Kazuhiro Hayashi, P.T., from Nagoya University Hospital in Japan, and colleagues investigated the association between preoperative 6MWD with POCD in...
Guest Post: This is a guest article by Clifford M. Thornton, a Certified Cardiovascular Technologist, experienced Echocardiographer Technician, and journalist in the cardiac and medical device fields. His articles have been published in Inventor’s Digest, Global Innovation Magazine, and Modern Health Talk. He is enthusiastic about progress with cardiac stem cell therapies and their role in...
A small, preliminary study could trigger a paradigm shift in the treatment of heart failure. The late-breaking research is published today in Circulation and presented at Heart Failure 2018 and the World Congress on Acute Heart Failure, a European Society of Cardiology congress. The study suggests that heart failure may be caused by inappropriate fluid shifts in some patients...
